Study Details

Evaluation of Patient Characteristics as Predictors of Acute Treatment Toxicity: A Feasibility Study

Robert L. Davis, Principal Investigator


This is a feasibility study with the intent of determining costs and feasibility of a larger study. The larger future study, a prospective cohort study, will determine the most accurate predictors of toxicity among clinical and genetic characteristics of patients receiving taxane-based therapies for malignancy. Toxic effects and survival are the primary endpoints to be assessed.
Funding source:

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente